CYP19A1 and breast carcinoma: SIRT1 not only perpetuates estrogen signaling in breast cancer cells by increasing aromatase and estrogen receptor expression but also facilitates their survival by enhancing the expression of antioxidative proteins and modulating p53 and cyclin D2 expression.